Marc Delord

6PUBLICATIONS
46CO-AUTHORS
Major global burdens of diseaseMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 05, 2025
Multiple states clustering analysis (MSCA), an unsupervised approach to multiple time-to-event electronic health records applied to multimorbidity associated with myocardial infarction.

Marc Delord, Abdel Douiri

|Oct 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Vincent Rondeau, Maria Kalogeraki, Lilian Roland

|Oct 17, 2024
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Patrice Chevallier, Thibaut Leguay, Marc Delord

|Jul 20, 2021
PLZF Acetylation Levels Regulate NKT Cell Differentiation.

Jihene Klibi, Claudine Joseph, Marc Delord

|Jan 23, 2021
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.

Francois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot

|May 01, 2019
Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.

Stéphanie Foulon, Pascale Cony-Makhoul, Agnès Guerci-Bresler

Pageof 1

Frequent Collaborators

1 joint publications

Stéphanie Foulon

1 joint publications

Francois Guilhot

1 joint publications

Alain Delmer

1 joint publications

Emmanuel Gyan